Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office

Phase III Trial Of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS (FSRS) For Resected Metastatic Brain Disease

Clinical Trial Details

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

Key Eligibility: 
  • Resected brain metastasis must be non-CNS primary site
  • Age ≥18 years
  • Ability to complete an MRI of the head with contrast
  • No prior whole brain radiation therapy
  • Must be fluent in English, Spanish, or French.

Detailed eligibility will be reviewed when you contact the study team.

Return to List

Study contact by location

Brooklyn

Contact(s)

Lina Flores, RN
(718) 965-9859
lif9061@nyp.org

Primary Investigator(s)

Hani Lamie Ashamalla, MD, FCCP

Protocol ID(s)

Weill Cornell Medicine IRB #:

1904020156

ClinicalTrials.gov:

NCT03180268

Sponsor:

NRG-BN003

Status

Open to Enrollment

Age Group

Adult

Sponsor

  • NRG Oncology

Disease

Brain Cancer
Meningioma